European medicines regulator authorises Pfizer COVID-19 vaccine

FILE PHOTO: A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration

AMSTERDAM (Reuters) - Europe's medicines regulator on Monday approved the use of the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech, putting Europe on course to start inoculations within a week.

European Union countries including Germany, Austria and Italy have said they plan to start vaccinations from Dec. 27 as Europe tries to catch up with the United States and Britain where the roll-out began earlier this month.

(Reporting by Bart Meijer; Writing by Keith Weir; editing by David Evans)